Back
Trevi Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
TRVI
Trevi Therapeutics, Inc.
Last Price:
$12.83
Seasonality Move:
59.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight selling pressure.
Trevi Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.64 | Buy |
| 20-day SMA: | 13.01 | Sell |
| 50-day SMA: | 11.86 | Buy |
| 200-day SMA: | 8.26 | Buy |
| 8-day EMA: | 10.58 | Buy |
| 20-day EMA: | 6.41 | Buy |
| 50-day EMA: | 3.1 | Buy |
| 200-day EMA: | 0.86 | Buy |
Trevi Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.5 | Buy |
| Relative Strength Index (14 RSI): | 54.27 | Buy |
| Chaikin Money Flow: | -128463 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.88 - 13.56) | Buy |
| Bollinger Bands (100): | (8.02 - 12.16) | Buy |
Trevi Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics, Inc. Stock
Is Trevi Therapeutics, Inc. Stock a Buy?
-
Trevi Therapeutics, Inc. share price is 12.85 while TRVI 8-day simple moving average is 12.64, which is a Buy signal.
-
The stock price of TRVI is 12.85 while Trevi Therapeutics, Inc. 20-day SMA is 13.01, which makes it a Sell.
-
Trevi Therapeutics, Inc. 50-day simple moving average is 11.86 while TRVI share price is 12.85, making it a Buy technically.
-
TRVI stock price is 12.85 and Trevi Therapeutics, Inc. 200-day simple moving average is 8.26, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
52
Trevi Therapeutics, Inc. (TRVI)
is a Buy
Is Trevi Therapeutics, Inc. a Buy or a Sell?
-
Trevi Therapeutics, Inc. stock is rated a BuyThe current Trevi Therapeutics, Inc. [TRVI] share price is $12.85. The Score for TRVI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics, Inc. Stock Info
Market Cap:
1.6B
Price in USD:
12.85
Share Volume:
1.2M
Trevi Therapeutics, Inc. 52-Week Range
52-Week High:
14.39
52-Week Low:
3.47
Buy
52
Trevi Therapeutics, Inc. (TRVI)
is a Buy
Trevi Therapeutics, Inc. Share Price Forecast
-
What is the Trevi Therapeutics, Inc. stock price today?The Trevi Therapeutics, Inc. stock price is 12.85 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics, Inc. is not overvalued.
Is Trevi Therapeutics, Inc. Stock a Buy?
-
Trevi Therapeutics, Inc. share price is 12.85 while TRVI 8-day exponential moving average is 10.58, which is a Buy signal.
-
The stock price of TRVI is 12.85 while Trevi Therapeutics, Inc. 20-day EMA is 6.41, which makes it a Buy.
-
Trevi Therapeutics, Inc. 50-day exponential moving average is 3.10 while TRVI share price is 12.85, making it a Buy technically.
-
TRVI stock price is 12.85 and Trevi Therapeutics, Inc. 200-day simple moving average is 0.86, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics, Inc.
Is Trevi Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Trevi Therapeutics, Inc.
Should I short Trevi Therapeutics, Inc. stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 3.5, suggesting Trevi Therapeutics, Inc. is a Buy
-
Trevi Therapeutics, Inc. Relative Strength Index (RSI) is 54.27, which suggest Trevi Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics, Inc. is (11.88 - 13.56), which suggest Trevi Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics, Inc. is (8.02 - 12.16), which suggest Trevi Therapeutics, Inc. is a Buy
* Trevi Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.